Nexalin trials Halo neurostimulation device in traumatic brain injury

Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation device, Gen-3 Halo headset, as an at-home treatment for mild traumatic brain injury.